2006
DOI: 10.1016/j.copbio.2006.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic potential of natural product signal transduction agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 51 publications
0
9
0
Order By: Relevance
“…In particular, the upregulation of peptidyl prolyl cis‐trans isomerase A, is noted here. Immunophilins bind natural product signal transduction modulators or immunophilin ligands (Bell, Monaghan & Page ; Koehn ). The role of this protein is not characterized in Atlantic salmon, given its marked upregulation in fish fed functional feeds; a further investigation of the function of this protein and its role in mediating a possible immunostimulatory role of functional feed ingredients in fish seems to be warranted.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the upregulation of peptidyl prolyl cis‐trans isomerase A, is noted here. Immunophilins bind natural product signal transduction modulators or immunophilin ligands (Bell, Monaghan & Page ; Koehn ). The role of this protein is not characterized in Atlantic salmon, given its marked upregulation in fish fed functional feeds; a further investigation of the function of this protein and its role in mediating a possible immunostimulatory role of functional feed ingredients in fish seems to be warranted.…”
Section: Discussionmentioning
confidence: 99%
“…These natural products have been key probes for understanding PPIase function and were even used to identify members of the PPIase family . Previous reviews have summarized the structure and function of PPIases, , their roles in disease, and the history of natural products as inhibitors. Here, we only briefly discuss these topics before focusing on understanding how natural products have informed recent developments in the search for selective, potent PPIase inhibitors.…”
Section: Introductionmentioning
confidence: 99%
“…In all cases, modifications were made in the one area, the C-43 alcoholic hydroxyl group that avoids both the FKBP-12 and the target of rapamycin (TOR) binding sites, since modifications in other areas would negate the basic biological activity of this molecule . For a further discussion on modification of molecules from a similar biosynthetic source (polyketide immunophilin ligands) one should consult the recent review by Koehn …”
Section: Discussion Of Specific Topicsmentioning
confidence: 99%